Trump administration halts use of human fetal tissue in NIH-funded research
The Trump administration announced a new policy on Thursday prohibiting the use of human fetal tissue derived from abortions in research funded by the National Institutes of Health (NIH). This expands restrictions implemented during Trump's first term, which were later lifted by the Biden administration.
Briefing Summary
AI-generatedThe Trump administration announced a new policy on Thursday prohibiting the use of human fetal tissue derived from abortions in research funded by the National Institutes of Health (NIH). This expands restrictions implemented during Trump's first term, which were later lifted by the Biden administration. While the NIH has funded research involving fetal tissue for decades, its use has declined since 2019, with only 77 projects using it in 2024. According to the NIH, this policy does not end the use of existing fetal cell lines. The NIH will also seek input on ways to reduce or replace reliance on human embryonic stem cells.
Article analysis
Model · rule-basedKey claims
5 extractedThe $47 billion agency counted just 77 projects funded in 2024 that included fetal tissue.
NIH Director Jay Bhattacharya acknowledged the agency “has long maintained policies governing the responsible and limited use of human fetal tissue in biomedical research.”
Opponents of fetal tissue use say there are now alternatives, although many scientists say there aren’t always adequate substitutes.
The government has funded research involving fetal tissue for decades, under both Republican and Democratic administrations.
The Trump administration announced Thursday that human fetal tissue derived from abortions can no longer be used in research funded by the National Institutes of Health.